Vici Health Sciences
Vici Health Sciences is a Maryland-based, full-service pharmaceutical CDMO founded in 2017 that provides formulation development, analytical testing, cGMP clinical and commercial manufacturing, and regulatory services to emerging pharma, biotech, and generic drug developers.
- Company typePrivate
- Founded2017
- HeadquartersElkridge, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Vici Health Sciences does
Vici Health Sciences is a Maryland-based, privately held contract development and manufacturing organization (CDMO) founded in 2017 that delivers end-to-end pharmaceutical product development services. Its service platform spans formulation development for oral solids, oral liquids, buccal, topical, injectable, and ophthalmic dosage forms; analytical method development, validation, and stability testing under ICH and FDA phase-appropriate frameworks; cGMP clinical supply manufacturing for Phase I–III studies; commercial-scale oral solid and liquid manufacturing at a 54,000 sq ft FDA-inspected facility; and regulatory services covering 505(b)(2), ANDA, IND, and NDA pathways, plus DEA Schedule I-V controlled substance handling. The company also runs a compounding pharmacy (Vici Rx) and small-batch nutraceutical/dietary supplement manufacturing.
The business is structured as a project-based professional services CDMO with quote-driven, multi-year contracts targeted primarily at emerging and virtual pharmaceutical companies, biotechs, and generic developers that lack internal R&D infrastructure. Pricing is opaque and varies by scope, with 505(b)(2) engagements ranging from under $5M to over $100M; a free CEO consultation and 5-business-day quote turnaround are the primary intake mechanisms, supplemented by industry conference presence (DCAT Week, CPHI, ChemOutsourcing, SupplySide Connect) and content marketing. Customers are US-anchored, partly due to SBIR-grant-driven demand for domestic manufacturing, though the company claims a global footprint via conference reach and controlled-substance import/export licensing.
The leadership team is built around co-founders CEO Dr. Anish Dhanarajan (20+ years pharma experience including Pfizer, GSK, CorePharma, and Mallinckrodt) and President Francesca Minale (13+ years, 20+ products filed, multiple patents). The firm reports a cumulative track record of 50+ formulations developed, 30+ clinical trials supported, and 15+ ANDA approvals, and underwent a notable 2024 expansion adding Phase III/commercial manufacturing, headcount, and physical footprint. Manufacturing scale-up and tech transfer to a sister manufacturing partner in Maryland enable the R&D-to-commercial continuum.
Vici Health Sciences firmographics
Firmographics- Name
- Vici Health Sciences
- Legal name
- Vici Health Sciences
- Website
- https://vicihealthsciences.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Vici Health Sciences is a Maryland-based, full-service pharmaceutical CDMO founded in 2017 that provides formulation development, analytical testing, cGMP clinical and commercial manufacturing, and regulatory services to emerging pharma, biotech, and generic drug developers.
- Ownership category
- akta.pro rank
Vici Health Sciences industry classification
Industry- Product category
- Pharmaceutical CDMO Services
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)
- akta.pro industry
- Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMOHealthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)Clinical Trial Material (CTM) Manufacturing & Supply CDMOHealthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)CMC & Pharmaceutical Development (Formulation/Process/Analytical Development)Drug Substance–Drug Product Integrated CDMOHealthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)Packaging, Labeling & Serialization (Clinical/Commercial) CDMOHealthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
Keywords
Where Vici Health Sciences is headquartered
LocationHeadquarters
- HQ city
- Elkridge
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Vici Health Sciences business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Contract Development and Manufacturing (CDMO) Services: Full-service pharmaceutical R&D and manufacturing services including formulation development, analytical testing, cGMP clinical supply manufacturing, and regulatory consulting. Revenue generated through project-based contracts for emerging pharmaceutical companies. Services are sold as comprehensive packages or standalone offerings.
- Regulatory Filing Services: FDA regulatory strategy and filing services including 505(b)(2) NDA, ANDA writing and filing, IND preparation and submission, and post-approval regulatory management. Billed as professional services or integrated into full development contracts.
- Clinical Supply Manufacturing: cGMP manufacturing of clinical trial materials for Phase I, II, and III studies. Revenue from batch manufacturing services for tablets, capsules, oral liquids, topical products, and custom synthesis.
- Contract Laboratory Testing Services: Standalone analytical testing services for pharmaceutical, nutraceutical, and dietary supplement companies. Includes ID testing, assay, impurities, dissolution, stability studies, and specialized testing for compounded drugs.
- Nutraceutical/Dietary Supplement Manufacturing: Contract manufacturing of dietary supplements for private label and brand owners. Includes formulation development, testing, and small batch manufacturing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Consultation Services |
| Other | Multi-year contract | Full-Service CDMO Package |
| Other | Pay-as-you-go | Compounding Pharmacy Services |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
Vici Health Sciences product offering
Product offeringCore offering
Vici Health Sciences is a US-based pharmaceutical Contract Development and Manufacturing Organization (CDMO) that delivers end-to-end drug development services from early formulation through commercial manufacturing. Services span formulation development (oral solids, liquids, buccal, topical, injectable, ophthalmic), analytical method development and validation, cGMP clinical supply manufacturing for Phase I-III, commercial-scale manufacturing at a 54,000 sq ft FDA-inspected facility, regulatory strategy and filing (505(b)(2) NDA, ANDA, IND), CMC consulting, nutraceutical/dietary supplement contract manufacturing, and a compounding pharmacy (Vici Rx).
Product overview
Vici Health Sciences is a full-service Contract Development and Manufacturing Organization (CDMO) providing end-to-end pharmaceutical R&D services. The company operates a unified platform combining Formulation Development, Analytical Testing, Clinical Supply Chain Management, Regulatory Services, and CMC Consulting. Core services include: oral solid and liquid dosage formulation development; analytical method development, validation, and testing (HPLC, dissolution, stability); cGMP clinical trial manufacturing from Phase I through Phase III and commercial scale; DEA-licensed controlled substance handling; regulatory filing services (505(b)(2), IND, NDA, ANDA); and specialized nutraceutical/dietary supplement manufacturing. The company also offers compounding pharmacy services through Vici Rx. Manufacturing capabilities span from small-scale R&D batches at the Maryland facility to 54,000 sq ft commercial-scale oral solid and liquid production.
Differentiator
Problem solved
Functional benefit
Products and services
- Formulation Development
Quantifiable outcome
- 50+ formulations developed
- +4 more outcomes
Companies that use Vici Health Sciences
Customer profileSegments7 records
Ideal customer profiles5 records
Vici Health Sciences technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Vici Health Sciences partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Sister Manufacturing Company (Maryland)coreVici partners with a sister manufacturing company also located in Maryland for Phase III clinical trial material manufacturing and commercial-scale production. This relationship enables seamless transition from R&D through commercial manufacturing with vertical integration of services. The partnership allows Vici to offer Phase III and commercial manufacturing capabilities while maintaining R&D focus.
Scale indicators9 records
Recent moves6 records
Expansion highlights6 records
Vici Health Sciences competitors and assessment
Company assessmentMarket position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Vici Health Sciences social profiles
Digital presenceVici Health Sciences compliance and trust
Trust signalCompliance4 records
Vici Health Sciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vici Health Sciences leadership team
Management profileNumber of profiles
Profiles2 records
Vici Health Sciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vici Health Sciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vici Health Sciences
What does Vici Health Sciences do?
Vici Health Sciences is a US-based pharmaceutical Contract Development and Manufacturing Organization (CDMO) that delivers end-to-end drug development services from early formulation through commercial manufacturing. Services span formulation development (oral solids, liquids, buccal, topical, injectable, ophthalmic), analytical method development and validation, cGMP clinical supply manufacturing for Phase I-III, commercial-scale manufacturing at a 54,000 sq ft FDA-inspected facility, regulatory strategy and filing (505(b)(2) NDA, ANDA, IND), CMC consulting, nutraceutical/dietary supplement contract manufacturing, and a compounding pharmacy (Vici Rx).
Is Vici Health Sciences a public or private company?
Vici Health Sciences is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Vici Health Sciences founded?
Vici Health Sciences was founded in 2017. It employs 11 to 50 people.
Where is Vici Health Sciences based?
Vici Health Sciences is headquartered in Elkridge, United States, in the North America region.
How does Vici Health Sciences make money?
Five revenue lines are on record. Contract Development and Manufacturing (CDMO) Services are the primary driver. The others are regulatory Filing Services, clinical Supply Manufacturing, contract Laboratory Testing Services and nutraceutical/Dietary Supplement Manufacturing.
Does Vici Health Sciences have an API?
No public API is recorded for Vici Health Sciences.
What industry is Vici Health Sciences in?
Vici Health Sciences's product category is Pharmaceutical CDMO Services. Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO. Its NAICS code is 325412 and its SIC code is 2834.